+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multiple fetal anomalies in the first trimester; detection using transvaginal ultrasound and therapeutic abortion using mifepristone (RU486) in conjunction with gemeprost vaginal pessaries



Multiple fetal anomalies in the first trimester; detection using transvaginal ultrasound and therapeutic abortion using mifepristone (RU486) in conjunction with gemeprost vaginal pessaries



British Journal of Obstetrics and Gynaecology 99(3): 258-259




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040751060

Download citation: RISBibTeXText

PMID: 1606124

DOI: 10.1111/j.1471-0528.1992.tb14509.x


Related references

A random allocation comparison of intracervical prostaglandin e 2 and gemeprost vaginal pessaries for induction of second trimester abortion. Journal of Obstetrics & Gynaecology (Abingdon) 10(2): 117-119, 1989

Comparison of gemeprost and vaginal misoprostol in first trimester mifepristone-induced abortion. Contraception 72(1): 28-32, 2005

A comparison of the efficacy of gemeprost vaginal pessaries and extra-amniotic prostaglandin E2 gel in the induction of middle trimester abortion. Journal of Obstetrics and Gynaecology 10(4): 304-305, 1990

Oral Mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion: An open multicenter study. Contraception 56(6): 361-366, 1997

Incidence of uterine rupture in second trimester abortion with gemeprost alone compared to mifepristone and gemeprost. Contraception 2018, 2018

Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost). Contraception 39(5): 497-502, 1989

The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486). Human Reproduction 8(10): 1744-1746, 1993

Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study. American Journal of Obstetrics and Gynecology 193(3 Pt 2): 1260-1265, 2005

Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost. Acta Obstetricia et Gynecologica Scandinavica 72(1): 39-42, 1993

Gemeprost vaginal pessaries for inducing third-trimester intrauterine deaths. British Journal of Obstetrics and Gynaecology 97(4): 366, 1990

Termination of third-trimester pregnancy before term with gemeprost vaginal pessaries. Acta Obstetricia et Gynecologica Scandinavica 81(6): 523-526, 2002

Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprost. Australian and New Zealand Journal of Obstetrics and Gynaecology 36(1): 20-23, 1996

Induction of second trimester abortion with mifepristone and gemeprost. British Journal Of Obstetrics & Gynaecology. 100(8): 758-761, 1993

A comparison of Lamicel tents and gemeprost (Cervagem) pessaries prior to first trimester abortion. Archives of Gynecology and Obstetrics 249(2): 67-72, 1991

Therapeutic abortion intrauterine fetal death in the second trimester. Treatment with a gemeprost-sulprostone combination. Minerva Ginecologica 49(9): 383-391, 1998